AdvanCell
Develops lead-212 targeted alpha therapies to treat cancer
$315MSeries D
Role not disclosedLoading investors…
Activity from announced rounds
Pitching Brandon Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room